4.5 Review

Epidemiology and mortality of Cushing's syndrome

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2021.101521

Keywords

Cushing's syndrome; Cushing's disease; mild autonomous cortisol secretion; incidence; prevalence; standardised mortality ratio (SMR)

Ask authors/readers for more resources

Endogenous Cushing's syndrome is a rare endocrine disorder characterized by excess cortisol secretion. Patients with active CS have elevated mortality rates, primarily due to cardiovascular disease. Early diagnosis, prompt treatment, and strict control of cardiovascular risk factors are crucial for the long-term prognosis of these patients.
Endogenous Cushing's syndrome (CS) is a rare endocrine disorder characterised by excess cortisol secretion due to either ACTH-dependent conditions [commonly an ACTH-producing pituitary adenoma (Cushing's disease)] or ACTH-independent causes (with most common aetiology being a benign adrenal adenoma). Overall, the annual incidence of CS ranges between 1.8 and 3.2 cases per million population. Mortality in active CS is elevated compared to the general population, and a number of studies support the view that survival is also compromised even after apparent successful treatment. The main cause of death is cardiovascular disease highlighting the negative impact of cortisol excess on cardiovascular risk factors. Early diagnosis and prompt treatment of the cortisol excess, as well as vigilant monitoring and stringent control of cardiovascular risk factors are key elements for the long-term prognosis of these patients. (C) 2021 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available